13F-HR filed by BOONE CAPITAL MANAGEMENT LLC
BOONE CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 21 holding rows worth $494,419,001.
- Accession
- 0001214659-24-009294
- Filer
- CIK 1882053
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 21 entries on the cover page, a total value of $494,419,001 stated on the cover page (in dollars after the unit check, H1), rows summing to $494,419,001 with VALUE read as dollars as filed, 13F file number 028-23055. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| UNUM GROUP COM | 91529Y106 | Stock | 1,025,027 | $55,002,949 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 131,926 | $47,914,204 | dollars as filed | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 85,716 | $35,214,704 | dollars as filed | |
| ENOVIS CORPORATION | 194014502 | COM | 562,739 | $35,143,051 | dollars as filed | |
| BAXTER INTL INC | 071813109 | COM | 697,957 | $29,830,682 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 529,825 | $28,419,813 | dollars as filed | |
| BERRY GLOBAL GROUP INC | 08579W103 | COM | 450,101 | $27,222,108 | dollars as filed | |
| AMPHASTAR PHARMACEUTICALS IN | 03209R103 | COM | 606,688 | $26,639,670 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 310,462 | $25,457,884 | dollars as filed | |
| BIO RAD LABS INC | 090572207 | CL A | 72,344 | $25,021,619 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 531,967 | $23,342,712 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 609,104 | $22,140,930 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 65,811 | $16,434,323 | dollars as filed | |
| MESA LABS INC COM | 59064R109 | Stock | 133,394 | $14,637,324 | dollars as filed | |
| ORTHOFIX MED INC | 68752M108 | COM | 974,502 | $14,149,769 | dollars as filed | |
| VIATRIS INC COM | 92556V106 | Stock | 1,133,591 | $13,535,077 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 291,403 | $12,544,899 | dollars as filed | |
| HEALTHCARE SVCS GROUP INC | 421906108 | COM | 926,455 | $11,562,158 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 451,898 | $11,351,678 | dollars as filed | |
| PENNANT GROUP INC | 70805E109 | COM | 564,192 | $11,075,089 | dollars as filed | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 330,151 | $7,778,358 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-24-009294 | this filing | 2024-05-15 | acceptance time not in the bulk data set |